Deeter Investments’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$766K Buy
+80,898
New +$896K 0.11% 88

Other funds holding CAPR

Deeter Investments's CAPR Position: Q3 2026 in Review

Deeter Investments opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 80,898 shares worth $766K. The stake represents 0.11% of the portfolio and ranks #88 among its holdings.

158 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Deeter Investments held 80,898 shares of Capricor Therapeutics worth $766K as of Q3 2026.
  • Capricor Therapeutics was a new Deeter Investments position in Q3 2026.
  • Capricor Therapeutics made up 0.11% of Deeter Investments's portfolio in Q3 2026, its #88 holding.
  • 158 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Deeter Investments's 13F filing for Q3 2026, filed 16 Nov 2026.